Rigel Pharmaceuticals, Inc. (RIGL)
45.16
-0.72
(-1.58%)
USD |
NASDAQ |
Aug 24, 16:00
45.16
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Liabilities (Quarterly) : 95.64M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.64M |
| March 31, 2026 | 104.71M |
| December 31, 2025 | 169.14M |
| September 30, 2025 | 124.92M |
| June 30, 2025 | 124.80M |
| March 31, 2025 | 157.40M |
| December 31, 2024 | 489.92M |
| September 30, 2024 | 154.06M |
| June 30, 2024 | 158.32M |
| March 31, 2024 | 158.19M |
| December 31, 2023 | 145.87M |
| September 30, 2023 | 147.16M |
| June 30, 2023 | 145.21M |
| March 31, 2023 | 147.87M |
| December 31, 2022 | 147.90M |
| September 30, 2022 | 135.44M |
| June 30, 2022 | 131.68M |
| March 31, 2022 | 142.28M |
| December 31, 2021 | 136.95M |
| September 30, 2021 | 136.85M |
| June 30, 2021 | 133.49M |
| March 31, 2021 | 137.70M |
| December 31, 2020 | 76.35M |
| September 30, 2020 | 72.10M |
| June 30, 2020 | 74.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 64.86M |
| December 31, 2019 | 93.75M |
| September 30, 2019 | 87.15M |
| June 30, 2019 | 77.87M |
| March 31, 2019 | 77.47M |
| December 31, 2018 | 29.23M |
| September 30, 2018 | 19.70M |
| June 30, 2018 | 17.65M |
| March 31, 2018 | 19.01M |
| December 31, 2017 | 18.46M |
| September 30, 2017 | 15.08M |
| June 30, 2017 | 15.87M |
| March 31, 2017 | 17.24M |
| December 31, 2016 | 23.11M |
| September 30, 2016 | 22.70M |
| June 30, 2016 | 25.60M |
| March 31, 2016 | 32.83M |
| December 31, 2015 | 40.37M |
| September 30, 2015 | 42.76M |
| June 30, 2015 | 47.20M |
| March 31, 2015 | 53.54M |
| December 31, 2014 | 25.89M |
| September 30, 2014 | 16.37M |
| June 30, 2014 | 16.70M |
| March 31, 2014 | 14.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 446.97M |
| Cytokinetics, Inc. | 2.098B |
| Perspective Therapeutics, Inc. | 68.16M |
| Capricor Therapeutics, Inc. | 122.52M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 521.07M |
| Shareholders Equity (Quarterly) | 425.42M |
| Debt to Equity Ratio | 0.0939 |
| Current Ratio | 1.941 |
| Net Debt Paydown Yield | 0.58% |